SCHEMBL9710367

SCHEMBL9710367

O=C(COc1c(Cl)cccc1Cl)Nc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.62
POLB P06746 3/20 0.56
MEN1 O00255 4/20 0.56
LMNA P02545 2/20 0.56
ALDH1A1 P00352 2/20 0.56
NPC1 O15118 9/20 0.55
RAB9A P51151 7/20 0.55
NOTUM Q6P988 2/20 0.55
TDP1 Q9NUW8 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.54
HPGD P15428 1/20 0.51
MAPK1 P28482 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5638709 0.86 KMT2A (0.70) KMT2APOLBMEN1LMNANPC1
SCHEMBL25977944 0.84 CYP1A2 (0.65) KMT2AMEN1LMNAALDH1A1NPC1
SCHEMBL10726989 0.79 NPSR1 (0.64) KMT2APOLBMEN1LMNAALDH1A1
SCHEMBL27903404 0.79 RAB9A (0.76) KMT2AMEN1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL9722714 0.79 RAB9A (0.64) KMT2APOLBMEN1LMNAALDH1A1
SCHEMBL11226437 0.78 L3MBTL1 (0.67) KMT2AMEN1LMNAALDH1A1NPC1
SCHEMBL11082064 0.78 NOTUM (0.63) KMT2APOLBMEN1LMNAALDH1A1
SCHEMBL4208290 0.78 MEN1 (0.51) KMT2APOLBMEN1ALDH1A1NPC1
SCHEMBL3498895 0.78 LMNA (0.78) KMT2AMEN1LMNAALDH1A1NPC1
SCHEMBL3729436 0.77 KMT2A (1.00) KMT2ALMNAALDH1A1TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114516813-B Continuous flow preparation method of diclofenac sodium 复旦大学 2024-05-28 CN claimed
US-11905229-B2 Method for synthesizing diclofenac sodium FUDAN UNIVERSITY (CN) 2024-02-20 US claimed
US-11834388-B2 Continuous-flow preparation method of diclofenac sodium FUDAN UNIVERSITY (CN) 2023-12-05 US claimed
CN-114539086-B Synthesis method of diclofenac sodium 复旦大学 2023-10-03 CN claimed
US-20230234911-A1 METHOD FOR SYNTHESIZING DICLOFENAC SODIUM FUDAN UNIVERSITY (CN) 2023-07-27 US claimed
US-20230192595-A1 CONTINUOUS-FLOW PREPARATION METHOD OF DICLOFENAC SODIUM FUDAN UNIVERSITY (CN) 2023-06-22 US claimed
CN-114539086-A Method for synthesizing diclofenac sodium 复旦大学 2022-05-27 CN claimed
CN-114516813-A Continuous flow preparation method of diclofenac sodium 复旦大学 2022-05-20 CN claimed
CN-114516813-B Continuous flow preparation method of diclofenac sodium 复旦大学 2024-05-28 CN disclosed
US-11905229-B2 Method for synthesizing diclofenac sodium FUDAN UNIVERSITY (CN) 2024-02-20 US disclosed
US-11905229-B2 Method for synthesizing diclofenac sodium FUDAN UNIVERSITY (CN) 2024-02-20 US disclosed
US-11834388-B2 Continuous-flow preparation method of diclofenac sodium FUDAN UNIVERSITY (CN) 2023-12-05 US disclosed
CN-114539086-B Synthesis method of diclofenac sodium 复旦大学 2023-10-03 CN disclosed
US-20230234911-A1 METHOD FOR SYNTHESIZING DICLOFENAC SODIUM FUDAN UNIVERSITY (CN) 2023-07-27 US disclosed
US-20230192595-A1 CONTINUOUS-FLOW PREPARATION METHOD OF DICLOFENAC SODIUM FUDAN UNIVERSITY (CN) 2023-06-22 US disclosed
CN-114539086-A Method for synthesizing diclofenac sodium 复旦大学 2022-05-27 CN disclosed
CN-114516813-A Continuous flow preparation method of diclofenac sodium 复旦大学 2022-05-20 CN disclosed
CN-103113236-A Preparation method of 2,6-dichlorodiphenylamine HENAN DONGTAI PHARM CO LTD 2013-05-22 CN disclosed
WO-1992022522-A1 A PROCESS FOR THE PREPARATION OF N-(2,6-DICHLOROPHENYL)-N-PHENYL-N-(CHLOROACETYL)-AMINE LABORATORIO CHIMICO INTERNAZIONALE S.P.A. (IT) 1992-12-23 WO disclosed
WO-1992022522-A1 A PROCESS FOR THE PREPARATION OF N-(2,6-DICHLOROPHENYL)-N-PHENYL-N-(CHLOROACETYL)-AMINE LABORATORIO CHIMICO INTERNAZIONALE S.P.A. (IT) 1992-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11905229-B2 Method for synthesizing diclofenac sodium SULT2A1, CRYAA, AADAC KMT2A 1494/4885POLB 2377/4885MEN1 4422/4885
US-20230234911-A1 METHOD FOR SYNTHESIZING DICLOFENAC SODIUM SULT2A1, CRYAA, AADAC KMT2A 1494/4885POLB 2377/4885MEN1 4422/4885
US-20230192595-A1 CONTINUOUS-FLOW PREPARATION METHOD OF DICLOFENAC SODIUM SULT2A1, NIT2, CA2 KMT2A 1210/4885POLB 3467/4885MEN1 4501/4885
US-11834388-B2 Continuous-flow preparation method of diclofenac sodium SULT2A1, NIT2, CA2 KMT2A 1097/4885POLB 3453/4885MEN1 4476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.